Luke H. BRADLEY,Don Marshall GASH,Greg A. GERHARDT
申请号：
US15193605
公开号：
US20180117113A1
申请日:
2016.06.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.
